PDF (1298K)
摘要
2 型糖尿病(type 2 diabetes,T2DM)是常见的异质性疾病,随着人口老龄化和社会经济发展引起的生活方式改变,T2DM 发病率逐年上升,且其发病机制复杂,现有药物治疗时,难以同时保证疗效显著而副作用低。中药单体因来源广泛、药理活性丰富和相对安全等特点,具有广阔的应用前景。本文综述了核因子 Kappa B(nuclear factor kappa-B, NF-κB)、 磷脂酰肌醇 3-激酶(phosphatidylinositol 3-kinase,PI3K)/蛋白激酶 B(protein kinase B,Akt)、腺苷酸活化蛋白激酶(adenosine monophosphate-activated protein kinase, AMPK)、 核转录因子红系 2 相关因子 2(nuclear factor-erythroid 2-related factor 2, Nrf2)/ 抗氧化反应元件(antioxidant response element,ARE)等信号通路在 T2DM 发病中的作用机制、中药单体对这些通路的调控机制进展及面临的挑战。
Abstract
Type 2 diabetes (T2DM) is a common heterogeneous disease. With the change of lifestyle caused by aging population and social and economic development, the incidence rate of T2DM is increasing year by year, and its pathogenesis is complex. It is difficult to ensure significant efficacy and low side effects when existing drugs are used. Traditional Chinese medicine monomers have broad application prospects due to their wide sources, rich pharmacological activity, and relative safety. This article reviews the mechanisms of action of signaling pathways such as NF-κB, PI3K/Akt, AMPK, and Nrf2/ARE in the pathogenesis of T2DM, the progress of regulatory mechanisms of traditional Chinese medicine monomers on these pathways, and the challenges they face.
关键词
Key words
[Author(id=1330571773134508606, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=840734151@qq.com, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330571773214200385, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, authorId=1330571773134508606, language=EN, stringName=Yuanjun ZHANG, firstName=Yuanjun, middleName=null, lastName=ZHANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1 Department of Endocrinology, Gansu Provincial People's Hospital
2 Gansu Clinical Research Center for Metabolic Diseases, Lanzhou 730000, Gansu, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330571773268726340, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, authorId=1330571773134508606, language=CN, stringName=张媛君, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1 甘肃省人民医院 内分泌科
2 甘肃省代谢性疾病临床医学研究中心,兰州 730000,甘肃, bio={"content":"张媛君,女,副主任医师,研究方向:中西医结合防治内分泌与代谢性疾病研究。 E-mail:840734151@qq.com
"}, bioImg=null, bioContent=张媛君,女,副主任医师,研究方向:中西医结合防治内分泌与代谢性疾病研究。 E-mail:840734151@qq.com
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330571772983513649, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, xref=1, ext=[AuthorCompanyExt(id=1330571773000290866, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571772983513649, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Department of Endocrinology, Gansu Provincial People's Hospital), AuthorCompanyExt(id=1330571773012873780, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571772983513649, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 甘肃省人民医院 内分泌科)]), AuthorCompany(id=1330571773059011126, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, xref=2, ext=[AuthorCompanyExt(id=1330571773075788344, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571773059011126, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2 Gansu Clinical Research Center for Metabolic Diseases, Lanzhou 730000, Gansu, China), AuthorCompanyExt(id=1330571773088371258, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571773059011126, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2 甘肃省代谢性疾病临床医学研究中心,兰州 730000,甘肃)])]), Author(id=1330571773314863688, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330571773377778253, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, authorId=1330571773314863688, language=EN, stringName=Jing MA, firstName=Jing, middleName=null, lastName=MA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Department of Endocrinology, Gansu Provincial People's Hospital, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330571773428109904, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, authorId=1330571773314863688, language=CN, stringName=马婧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 甘肃省人民医院 内分泌科, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330571772983513649, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, xref=1, ext=[AuthorCompanyExt(id=1330571773000290866, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571772983513649, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Department of Endocrinology, Gansu Provincial People's Hospital), AuthorCompanyExt(id=1330571773012873780, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571772983513649, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 甘肃省人民医院 内分泌科)])]), Author(id=1330571773478441556, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330571773545550425, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, authorId=1330571773478441556, language=EN, stringName=Juxiang LIU, firstName=Juxiang, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 Department of Endocrinology, Gansu Provincial People's Hospital, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330571773600076380, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, authorId=1330571773478441556, language=CN, stringName=刘菊香, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1 甘肃省人民医院 内分泌科, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330571772983513649, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, xref=1, ext=[AuthorCompanyExt(id=1330571773000290866, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571772983513649, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Department of Endocrinology, Gansu Provincial People's Hospital), AuthorCompanyExt(id=1330571773012873780, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571772983513649, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 甘肃省人民医院 内分泌科)])]), Author(id=1330571773662990943, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=quanjxxt@163.com, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330571773742682726, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, authorId=1330571773662990943, language=EN, stringName=Jinxin QUAN, firstName=Jinxin, middleName=null, lastName=QUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1 Department of Endocrinology, Gansu Provincial People's Hospital
2 Gansu Clinical Research Center for Metabolic Diseases, Lanzhou 730000, Gansu, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330571773797208680, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, authorId=1330571773662990943, language=CN, stringName=权金星, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1 甘肃省人民医院 内分泌科
2 甘肃省代谢性疾病临床医学研究中心,兰州 730000,甘肃, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330571772983513649, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, xref=1, ext=[AuthorCompanyExt(id=1330571773000290866, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571772983513649, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 Department of Endocrinology, Gansu Provincial People's Hospital), AuthorCompanyExt(id=1330571773012873780, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571772983513649, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1 甘肃省人民医院 内分泌科)]), AuthorCompany(id=1330571773059011126, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, xref=2, ext=[AuthorCompanyExt(id=1330571773075788344, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571773059011126, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2 Gansu Clinical Research Center for Metabolic Diseases, Lanzhou 730000, Gansu, China), AuthorCompanyExt(id=1330571773088371258, tenantId=1045748351789510663, journalId=1155139928303341788, articleId=1330554196924568041, companyId=1330571773059011126, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2 甘肃省代谢性疾病临床医学研究中心,兰州 730000,甘肃)])])]
张媛君,马婧,刘菊香,权金星.
中药单体靶向调控糖尿病相关信号转导通路的分子药理学机制研究进展[J].
中国临床药理学与治疗学, 2026, 31(8): 1135-1143 DOI:10.12092/j.issn.1009-2501.2026.08.014
| [1] |
Ogurtsova K, Guariguata L, Barengo NC, et al. IDF diabetes Atlas: global estimates of undiagnosed diabetes in adults for 2021[J].Diabetes Res Clin Pract, 2022, 183(1): 109-118.
|
| [2] |
Ortiz-Martínez M, González-González M, Martagón AJ, et al. Recent developments in biomarkers for diagnosis and screening of Type 2 diabetes mellitus[J].Curr Diab Rep, 2022, 22(3): 95-105.
|
| [3] |
Yadav JP, Verma A, Pathak P, et al. Phytoconstituents as modulators of NF-κB signalling: investigating therapeutic potential for diabetic wound healing[J].Biomed Pharmacother, 2024, 173: 117058.
|
| [4] |
Sahukari R, Punabaka J, Bhasha S, et al. Plant compounds for the treatment of diabetes, a metabolic disorder: NF-κB as a therapeutic target[J].Curr Pharm Des, 2020, 26(39): 4955-4969.
|
| [5] |
Wasim R, Azmi S, Owais M, et al. Curcumin in type 2 diabetes mellitus: a natural approach to modulating metabolic dysfunction[J].Drug Res (Stuttg), 2025, 75(7): 251-260.
|
| [6] |
Qihui L, Shuntian D, Xin Z, et al. Protection of curcumin against streptozocin-induced pancreatic cell destruction in T2D rats[J].Planta Med, 2020, 86(2): 113-120.
|
| [7] |
Yaikwawong M, Jansarikit L, Jirawatnotai S, et al. Curcumin for inflammation control in individuals with Type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial[J].Nutrients, 2025, 17(12): 1972.
|
| [8] |
Asghari KM, Saleh P, Salekzamani Y, et al. The effect of curcumin and high-content eicosapentaenoic acid supplementations in type 2 diabetes mellitus patients: a double-blinded randomized clinical trial[J].Nutr Diabetes, 2024, 14(1): 14.
|
| [9] |
Yang QQ, Fan JD, Liu CY, et al. Physiological and transcriptome analysis of changes in endogenous hormone contents and related synthesis and signaling genes during the heat stress in garlic (Allium sativum L.)[J].BMC Plant Biol, 2025, 25(1): 464.
|
| [10] |
Ali SI, Elkhalifa AME, Nabi SU, et al. Aged garlic extract preserves beta-cell functioning via modulation of nuclear factor kappa-B (NF-κB)/Toll-like receptor (TLR)-4 and sarco endoplasmic reticulum calcium ATPase (SERCA)/Ca2+ in diabetes mellitus[J].Diabetol Metab Syndr, 2024, 16(1): 110.
|
| [11] |
Hamal S, Cherukuri L, Birudaraju D, et al. Short-term impact of aged garlic extract on endothelial function in diabetes: a randomized, double-blind, placebo-controlled trial[J].Exp Ther Med, 2020, 19(2): 1485-1489.
|
| [12] |
Atkin M, Laight D, Cummings MH. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial[J].J Diabetes Complications, 2016, 30(4): 723-727.
|
| [13] |
Yang L, Hu Y, Zhou G, et al. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K/AKT, p38 and ERK MAPK signaling pathways[J].Biosci Rep, 2020, 40(7): BSR20193137.
|
| [14] |
Yang YY, Qi JJ, Jiang SY, et al. Esculin ameliorates obesity-induced insulin resistance by improving adipose tissue remodeling and activating the IRS1/PI3K/AKT/GLUT4 pathway[J].J Ethnopharmacol, 2024, 319(Pt 2): 117251.
|
| [15] |
Feng Y, Ren Y, Zhang X, et al. Metabolites of traditional Chinese medicine targeting PI3K/AKT signaling pathway for hypoglycemic effect in type 2 diabetes[J].Front Pharmacol, 2024, 15: 1373711.
|
| [16] |
Oggero J, Gasser FB, Zacarías SM, et al. PEGylation of chrysin improves its water solubility while preserving the in vitro biological activity[J].J Agric Food Chem, 2023, 71(49): 19817-19831.
|
| [17] |
Zhou YJ, Xu N, Zhang XC, et al. Chrysin improves glucose and lipid metabolism disorders by regulating the AMPK/PI3K/AKT signaling pathway in insulin-resistant HepG2 cells and HFD/STZ-induced C57BL/6J mice[J].J Agric Food Chem, 2021, 69(20): 5618-5627.
|
| [18] |
Ahmadzadeh AM, Aliabadi MM, Mirheidari SB, et al. Beneficial effects of resveratrol on diabetes mellitus and its complications: focus on mechanisms of action[J].Naunyn Schmiedebergs Arch Pharmacol, 2025, 398(3): 2407-2442.
|
| [19] |
Sun X, Cao Z, Ma Y, et al. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis via activating the PI3K/Akt pathway and suppressing the FoxO1 pathway in type 2 diabetes[J].Food Funct, 2021, 12(3): 1207-1218.
|
| [20] |
Youjun D, Huang Y, Lai Y, et al. Mechanisms of resveratrol against diabetic wound by network pharmacology and experimental validation[J].Ann Med, 2023, 55(2): 2280811.
|
| [21] |
Ning L, Liu S, Gao L, et al. Influence of dietary fermented Folium mori on growing performance, lipometabolism and disease resistance of golden pompano Trachinotus ovatus[J].Fish Shellfish Immunol, 2022, 128(9): 398-404.
|
| [22] |
Cai S, Sun W, Fan Y, et al. Effect of mulberry leaf (Folium Mori) on insulin resistance via IRS-1/PI3K/Glut-4 signalling pathway in type 2 diabetes mellitus rats[J].Pharm Biol, 2016, 54(11): 2685-2691.
|
| [23] |
Sun Y, Zhang Y, Niu X, et al. Postprandial glycemic effects of lactose-hydrolyzed milk supplemented with mulberry leaf and corn silk extracts in adults with type 2 diabetes: a randomized crossover trial[J].Clin Nutr ESPEN, 2025, 67(3): 549-554.
|
| [24] |
Kido K, Eskesen NO, Henriksen NS, et al. AMPKγ3 controls muscle glucose uptake in recoveryfrom exercise to recapture energy stores[J].Diabetes, 2023, 72(10): 1397-1408.
|
| [25] |
Tokumitsu H, Sakagami H.Molecular mechanisms underlying Ca(2+)/calmodulin-dependent protein kinase kinase signal transduction[J].Int J Mol Sci, 2022, 23(19): 11025.
|
| [26] |
苏蓓蓓, 杨丽霞, 梁永林, 等. 大黄糖络丸通过AMPK_mTOR_ULK1通路调控糖尿病肾病小鼠足细胞自噬的作用机制研究[J].中国临床药理学与治疗学, 2024, 29(3): 260-269.
|
| [27] |
Steinberg GR, Hardie DG.New insights into activation and function of the AMPK[J].Nat Rev Mol Cell Biol, 2023, 24(4): 255-272.
|
| [28] |
Tan YF, Wang RQ, Wang WT, et al. Study on the pharmacokinetics, tissue distribution and excretion of laurolitsine from Litsea glutinosa in Sprague-Dawley rats[J].Pharm Biol, 2021, 59(1): 884-892.
|
| [29] |
Yong Z, Ruiqi W, Yanan Y, et al. Laurolitsine ameliorates type 2 diabetes by regulating the hepatic LKB1-AMPK pathway and gut microbiota[J].Phytomedicine, 2022, 106: 154423.
|
| [30] |
Vazirian M, Nabavi SM, Jafari S, et al. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities[J].Food Chem Toxicol, 2018, 122(12): 69-79.
|
| [31] |
Esquejo RM, Salatto CT, Delmore J, et al. Activation of Liver AMPK with PF-06409577 corrects NAFLD and lowers cholesterol in rodent and primate preclinical models[J].EBioMedicine, 2018, 31(5): 122-132.
|
| [32] |
Song Y, Lv X, Ding C, et al. Research progress on the bioactivity of platycodin D from Platycodon grandifloras[J].Naunyn Schmiedebergs Arch Pharmacol, 2025, 398(8): 9673-9701.
|
| [33] |
Shen Q, Zhong YT, Liu XX, et al. Platycodin D ameliorates hyperglycaemia and liver metabolic disturbance in HFD/STZ-induced type 2 diabetic mice[J].Food Funct, 2023, 14(1): 74-86.
|
| [34] |
Ebrahimi R, Mohammadpour A, Medoro A, et al. Exploring the links between polyphenols, Nrf2, and diabetes: a review[J].Biomed Pharmacother, 2025, 186: 118020.
|
| [35] |
Robertson RP.Nrf2 and antioxidant response in animal models of Type 2 diabetes[J].Int J Mol Sci, 2023, 24(4): 3082.
|
| [36] |
王文娟, 齐鸣瑞, 田利民. Nrf2 在糖尿病心肌病中的作用及中药干预研究进展[J].中国临床药理学与治疗学, 2022, 27(10): 1163-1170.
|
| [37] |
Qin S, Chen Z, Wen Y, et al. Phytochemical activators of Nrf2: a review of therapeutic strategies in diabetes[J].Acta Biochim Biophys Sin (Shanghai), 2022, 55(1): 11-22.
|
| [38] |
Chen KQ, Wang SZ, Lei HB, et al. Ophiopogonin D: review of pharmacological activity[J].Front Pharmacol, 2024, 15: 1401627.
|
| [39] |
Zhang H, Kang X, Ruan J, et al. Ophiopogonin D Improves Oxidative Stress and Mitochondrial Dysfunction in Pancreatic β Cells Induced by Hydrogen Peroxide through Keap1/Nrf2/ARE Pathway in Diabetes Mellitus[J].Chin J Physiol, 2023, 66(6): 494-502.
|
| [40] |
He M, Zhang Y, Zhai Y, et al. Trilobatin regulates glucose metabolism by ameliorating oxidative stress and insulin resistance in vivo and in vitro[J].J Pharm Pharmacol, 2025, 77(2): 236-248.
|
| [41] |
Shi YL, Zhang YP, Luo H, et al. Trilobatin, a natural food additive, exerts anti-type 2 diabetes effect mediated by Nrf2/ARE and IRS-1/GLUT2 signaling pathways[J].Front Pharmacol, 2022, 13: 828471.
|
| [42] |
Guo C, Huang Q, Wang Y, et al. Therapeutic application of natural products: NAD(+) metabolism as potential target[J].Phytomedicine, 2023, 114: 154768.
|
| [43] |
Singla RK, Joon S, Sinha B, et al. Current trends in natural products for the treatment and management of dementia: computational to clinical studies[J].Neurosci Biobehav Rev, 2023, 147: 105106.
|
基金资助
国家自然科学基金地区基金项目(81860091)
甘肃省重点研发计划项目(25YFFA047)
甘肃省卫生健康行业项目(GSWSKY2025-06)
甘肃省基础研究计划 -软科学专项(26JRZA147)